E-LIB Suche - Ergebnisse für: Radhakrishnan, Vivek S.

1

Bispecific antibodies in indolent B-cell lymphomas:

Radhakrishnan, Vivek S. ; Davies, Andrew J.
Frontiers in Immunology. 14 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

2

Antibody based therapies in Hodgkin lymphoma:

Radhakrishnan, Vivek S. ; Longley, Jemma ; Johnson, Peter W.M.
Cancer Treatment Reviews. 122 (2024) - p. 102647 , 2024

Link: https://doi.org/10.1016/..

3

Refractory Primary Mediastinal B-Cell Lymphoma: A Case Repo..:

Pincha, Rajat ; Radhakrishnan, Vivek S. ; Kumar, Jeevan...
Indian Journal of Medical and Paediatric Oncology. 43 (2022) 6 - p. 523-527 , 2022

Link: https://doi.org/10.1055/..

4

Peripheral T-Cell Lymphoma, Hemophagocytic Lymphohistiocyto..:

Guntiboina, Vinay Anand ; Radhakrishnan, Vivek S. ; Kumar, Jeevan...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) 10 - p. 780-784 , 2022

Link: https://doi.org/10.1016/..

5

Relapsed Refractory Hodgkin Lymphoma and Brentuximab Vedoti..:

Radhakrishnan, Vivek S. ; Bajaj, Rajat ; Raina, Vasundhara...
Frontiers in Oncology. 11 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

6

Comparison of Quality and Efficacy of Apheresis Platelets S..:

Basu, Debapriya ; Basu, Sabita ; Radhakrishnan, Vivek S....
Indian Journal of Hematology and Blood Transfusion. 37 (2021) 4 - p. 648-657 , 2021

Link: https://doi.org/10.1007/..

7

Myeloablative haploidentical t‐cell replete hematopoietic c..:

Shah, Sanket P. ; Radhakrishnan, Vivek S. ; Jaishetwar, Ganesh S....
ADVANCES IN CELL AND GENE THERAPY. 4 (2021) 2 - p. , 2021

Link: https://doi.org/10.1002/..

8

Systematic Review of the Burden and Treatment Patterns of A..:

Radhakrishnan, Vivek S. ; Agrawal, Narendra ; Bagal, Bhausaheb.
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) 1 - p. e85-e98 , 2021

Link: https://doi.org/10.1016/..

9

Precursor B‐cell acute lymphoblastic leukaemia—a global vie:

Biondi, Andrea ; Conter, Valentino ; Chandy, Mammen...
British Journal of Haematology. 196 (2021) 3 - p. 530-547 , 2021

Link: https://doi.org/10.1111/..

10

Inotuzumab Ozogamicin Monotherapy as an Outpatient Salvage ..:

Radhakrishnan, Vivek S. ; Modak, Ketan ; Bhave, Saurabh J....
Indian Journal of Medical and Paediatric Oncology. 42 (2021) 2 - p. 199-203 , 2021

Link: https://doi.org/10.1055/..

11

Outcomes of diffuse large B-cell lymphoma in elderly patien..:

Sarker, Chandrayee ; Radhakrishnan, Vivek S ; Mandal, Paya...
ecancermedicalscience. 15 (2021) - p. , 2021

Link: https://doi.org/10.3332/..

12

How I Treat Acute Promyelocytic Leukemia:

Nair, Reena ; Radhakrishnan, Vivek S.
Indian Journal of Medical and Paediatric Oncology. 42 (2021) 3 - p. 286-292 , 2021

Link: https://doi.org/10.1055/..

13

Thalidomide in Patients with Transfusion-Dependent E-Beta T..:

Nag, Arijit ; Radhakrishnan, Vivek S. ; Kumar, Jeevan...
Indian Journal of Hematology and Blood Transfusion. 36 (2020) 2 - p. 399-402 , 2020

Link: https://doi.org/10.1007/..

14

Blastic plasmacytoid dendritic cell neoplasm in a young fem..:

Modak, Ketan ; Garg, Jeevan Kumar ; Mishra, Deepak Kumar.
Indian Journal of Medical and Paediatric Oncology. 41 (2020) 5 - p. 761-763 , 2020

Link: https://doi.org/10.4103/..

15

Relapsed plasmablastic lymphoma in a HIV‐negative patient: ..:

Kathrotiya, Manthan ; Radhakrishnan, Vivek S ; Bhave, Saurabh J...
Clinical Case Reports. 9 (2020) 2 - p. 873-877 , 2020

Link: https://doi.org/10.1002/..